RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Évaluation économique a priori du dépistage de la rétinopathie diabétique par photographies du fond d‘œil
Launois, R., Le Moine, J-G., Raimond, V., Maunoury, F., Daher, I., & Akindélé, M. (2012). Évaluation économique a priori du dépistage de la rétinopathie diabétique par photographies du fond d‘œil. Journal d'économie médicale, 30(2), 79-95. https://doi.org/10.3917/jgem.122.0079
SUMMARY ECONOMIC EVALUATION OF EARLY SCREENING FOR DIABETIC RETINOPA-THY USING FUNDUS PHOTOGRAPHY Background: Diabetic retinopathy (DR) is the leading cause of blindness in people younger than 60 years in the general population. Objective: To assess the relevance and modalities of early screening for diabetic retinopa-thy using fundus photography. Methods: A Markov model based on a health insurance perspective was developed to eval-uate 17 screening strategies; the model simulated the fate of patient cohorts with or without diabetic retinopathy over 10 years. Six health states which mimicked the natural history of the disease were modeled: no retinopathy, background retinopathy, mild pre-proliferative retinopa-thy, sight threatening retinopathy, severe visual impairment, and death. Key modalities of the screening where type of screening (mass screening with or without dilatation, and opportunis-tic screening), rhythm (annual, biennial, or triennial) and addressing threshold. Yearly transi-tional probabilities were estimated from the Liverpool Diabetic Eyes study (LDES). Cost cal-culations were made from the point of view of prevention spending in relation to diabetic retinopathy and cost data was obtained from the French health insurance database. A discounting rate of 4% per annum was applied to each cost and effectiveness parameter. The cycle length was 12 months. The primary endpoint of the study was the number of prevented visual impair-ment. Cost-effective strategies were identified and deterministic sensitivity analysis was carried out on the results.